Wealth Enhancement Advisory Services, LLC Xeris Biopharma Holdings, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49.5 Billion
- Q4 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 16,268 shares of XERS stock, worth $90,775. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,268
Previous 12,675
28.35%
Holding current value
$90,775
Previous $42,000
30.95%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding XERS
# of Institutions
162Shares Held
61MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$57.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$44.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$18.7 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$18.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$16.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $759M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...